Resumo

OMAR, Junaid et al. A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir. Afr. j. prim. health care fam. med. (Online) [online]. 2021, vol.13, n.1, pp.1-3. ISSN 2071-2936.  http://dx.doi.org/10.4102/phcfm.v13i1.3088.

A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.

Palavras-chave : HIV; renal protection; health system improvement; South Africa; Dolutegravir.

        · texto em Inglês     · Inglês ( pdf )